Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of CD07387 Solution in Patients with Vitiligo
2010-019994-13Phase 2Completed
- Sponsor
- Galderma
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of CD07387 in Vitiligo (2 arms), sponsored by Galderma. Primary endpoint: Local tolerability. Started Sep 2010; status: completed.
02
Drugs
CD07387
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2010-019994-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019994-13.